2025. Comparative Efficacy of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Treatment Response in Atopic Dermatitis at Varying Treatment Continuance Rates. SKIN The Journal of Cutaneous Medicine. 9, 1 (Jan. 2025), s519. DOI:https://doi.org/10.25251/skin.9.supp.519.